NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Owkin

Owkin

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.owkin.com/

Last Round

Series B

Extension

Jun 8, 2022

Est. Valuation

$1B

Total Funding Raised

$356.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Owkin is a healthcare technology company that develops artificial intelligence and machine learning solutions to accelerate drug discovery, clinical development, and diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Revenue Share

AI Layer

Infrastructure

Keywords

federated learningagentic AIdrug discoveryclinical trial designai drug discoveryprecision medicinebiotech AIprivacy-preserving AIbiopharma R&Ddiagnostic developmentAI copilotpatient data analysisbiomedical research platformmultimodal clinical datavibe coding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Owkin Comps

Public and private peers based on sector, stage, and business model.

Owkin comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Owkin Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJun 8, 2022
Series BNov 18, 2021
Series AJun 30, 2020
Series A ExtensionMay 8, 2020
Series A ExtensionMar 7, 2019
Series A Extension
May 23, 2018

Key People

Founding team and executive leadership

Brian undefined

Chief Executive Officer

Executive Team

Pandu Kurniawan

Chief Executive Officer

Executive Team

Stella h

Principal CEO

Executive Team

Thomas Clozel

Chief Executive Officer And Co-founder

Founding Team

Owkin Investors

Notable investors and investment history

Owkin investors
InvestorRounds
GVSeries A, Series A Extension
Plug and Play Tech CenterSeries A
NJF CapitalSeries A, Series A Extension, Seed
Otium CapitalSeries A
F-Prime CapitalSeries A, Series A Extension
Eight Roads VenturesSeries A, Series A Extension
BpifranceSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2026

    Introduced Owkin Zero, an LLM fine-tuned on biology.

  • Mar 3, 2026

    Partnered with Consensus to integrate scientific literature intelligence.

Owkin Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Owkin Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Owkin's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range427
Year Founded2016
Last FundingJun 8, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.